Evidence-Based Recommendations for Monitoring and Antagonism of Neuromuscular Blockade: Overview of New Guidelines

In this interprofessional activity, expert faculty will discuss the recently released practice guidelines on monitoring and antagonism of neuromuscular blockade and use patient cases to develop an evidence-based approach for the management of neuromuscular monitoring during anesthesia and antagonism of neuromuscular blocking agents prior to extubation. Strategies to improve interprofessional collaboration in emergency situations to ensure that appropriate neuromuscular blockade use, monitoring, and reversal will also be shared.


Wednesday, Feb. 21
1 - 2 p.m. ET

Speakers 

Michael AlwanRachel C. Wolfe, PharmD, MHA, BCCCP
Activity Chair
Perioperative Clinical Pharmacy Specialist & Supervisor
Barnes-Jewish Hospital
St. Louis, Missouri


Madeline CamejoJ. Ross Renew, MD, FASA, FASE
Vice Chair for Research, Department of Anesthesiology and Perioperative Medicine, Associate Professor of Anesthesiology
Mayo Clinic
Jacksonville, Florida



Target Audience

This activity was planned to meet the educational needs of pharmacists, physicians, physician assistants, and nurse practitioners who care for patients in the perioperative setting. The pharmacist target audience also includes those who have a clinical, administrative, and/or patient safety focus in the perioperative setting.


Learning Objectives

  • Interpret recently released practice guidelines on monitoring and antagonism of neuromuscular blockade.
  • Develop an evidence-based approach for the management of neuromuscular monitoring during anesthesia and antagonism of neuromuscular blocking agents prior to extubation.
  • Apply strategies to improve interprofessional collaboration in emergency situations to ensure that appropriate neuromuscular blockade use, monitoring, and reversal is followed.

Agenda

  • 1:00 p.m. - Welcome and Introductions
    Rachel C. Wolfe
  • 1:05 p.m. - Evidence-Based Recommendations for Monitoring and Antagonism of Neuromuscular Blockade: Overview of New Guidelines
    Rachel C. Wolfe and J. Ross Renew
  • 1:50 p.m. - Questions and Answers
    All Faculty

Accredited for CPE and CME

ACPE #: 0204-0000-24-401-L01-P
CE Credit: 1.0 contact hour (0.10 CEU)
Activity Type: Application-based
Activity Fee: No charge 

To Claim CE for the webinar, enter the CE code announced during the activity and complete the evaluation.

 

 

ACPE logo black and white The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.
 ACCME logo

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The American Society of Health-System Pharmacists designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 ASHP Advantage logo Provided by ASHP.
Supported by an educational grant from Merck.
For questions and assistance to participate, contact us.